About Symetis
Symetis is a company based in Ecublens (Switzerland) founded in 2001 was acquired by Boston Scientific in March 2017. Symetis has raised $56.66 million across 3 funding rounds from investors including Boston Scientific, Truffle Capital and Endeavour Vision. Symetis has completed 1 acquisition, including Middle Peak Medical. Symetis operates in a competitive market with competitors including Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Peijia Medical Technologies, among others.
- Headquarter Ecublens, Switzerland
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$56.66 M (USD)
in 3 rounds
-
Latest Funding Round
$25.8 M (USD), Series C
Oct 07, 2010
-
Investors
Boston Scientific
& 11 more
-
Employee Count
Not available
- Investments & Acquisitions
-
Acquired by
Boston Scientific
(Mar 30, 2017)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Symetis
Symetis has successfully raised a total of $56.66M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $25.8 million completed in October 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Symetis
Symetis has secured backing from 12 investors, including venture fund and institutional investors. Prominent investors backing the company include Boston Scientific, Truffle Capital and Endeavour Vision.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Endeavour Vision is focused on transformative healthcare technology investments.
|
Locked | Locked | Locked | |
|
Truffle Capital is recognized as a leading European venture capital firm.
|
Locked | Locked | Locked | |
|
Investments are made in innovative life science companies globally.
|
Locked | Locked | Locked |
Investor details for Symetis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Symetis
Symetis has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Middle Peak Medical.
Investment portfolio details for Symetis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mitral valve disease implant technology is developed for cardiac interventions.
|
Locked | Locked | 2011 | Locked |
Complete acquisition details for Symetis
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Symetis
Detailed financials for Symetis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Symetis Comparisons
Peer comparison for Symetis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Symetis
Symetis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Shockwave Medical, Cardiac Dimensions, Venus MedTech, Pi-Cardia and Peijia Medical Technologies, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Cardiovascular balloon dilation catheters with lithotripsy electrodes are developed.
|
|
| Locked | Locked | Locked |
Invasive cardiac implants for heart failure treatment are developed.
|
|
| Locked | Locked | Locked |
Transcatheter aortic and pulmonic valves are developed for cardiovascular procedures.
|
|
| Locked | Locked | Locked |
Non-implant devices for cardiac valve repair are developed and manufactured.
|
|
| Locked | Locked | Locked |
Medical devices for cardiac and cerebrovascular treatments are developed.
|
Detailed competitors of Symetis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Symetis
Complete news archive for Symetis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Symetis
Symetis was founded in 2001 and raised its 1st funding round 3 years after it was founded.
Symetis is headquartered in Ecublens, Switzerland. It is registered at Ecublens, Vaud, Switzerland.
Symetis is a funded company, having raised a total of $56.66M across 3 funding rounds to date.
Symetis was founded in 2001 in Ecublens, Switzerland, within the medical devices sector focused on cardiac therapies. Minimally invasive replacement options for heart valve diseases are developed, including proprietary Acurate TA and Acurate neo systems with delivery mechanisms. These products are marketed across Europe and select international markets. Manufacturing operations are conducted in facilities located in Brazil and Switzerland. A planned initial public offering was suspended in late 2015.
Symetis's top competitors include Shockwave Medical, Cardiac Dimensions and JenaValve Technology.
Symetis has made 1 acquisition, including Middle Peak Medical.
Symetis has 12 investors. Key investors include Boston Scientific, Truffle Capital, Endeavour Vision, Novartis Venture Fund, and Wellington Partners Venture Capital.